Results 31 to 40 of about 92,469 (306)

Emerging therapies for pancreatic ductal carcinoma

open access: yesJournal of Solid Tumors, 2016
Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor mass that grows and metastasizes rapidly. There are no definitivemethods for early detection and most patients are diagnosed at a late stage. Those diagnosed at an early stage are eligible for tumorresection. However, many of these patients are soon burdened with tumor recurrence. The tumor grows
Robert Falcone   +3 more
openaire   +2 more sources

Pancreatic Metastasis of Breast Cancer: A Rare Cause of Obstructive Jaundice

open access: yesJournal of the Dow University of Health Sciences, 2015
The pancreas is a rare site of metastasis from malignant tumours. Pancreatic metastasis accounts for less than 5% of all pancreatic malignancies. The most common malignancies metastasizing to pancreas are the renal cell carcinoma, non-small cell lung ...
Mutahir A. Tunio   +3 more
doaj   +4 more sources

A Case of Pancreatic Intraepithelial Neoplasia That Was Difficult to Diagnose Preoperatively

open access: yesCase Reports in Oncology, 2015
A 63-year-old female patient presented to a local physician with pain in her back and epigastric region. An abdominal computed tomography (CT) scan revealed a pancreatic tumor, and the patient was referred to our hospital.
Hiroyuki Ito   +6 more
doaj   +1 more source

RelA regulates CXCL1/CXCR2-dependent oncogene-induced senescence in murine Kras-driven pancreatic carcinogenesis [PDF]

open access: yes, 2016
Tumor suppression that is mediated by oncogene-induced senescence (OIS) is considered to function as a safeguard during development of pancreatic ductal adenocarcinoma (PDAC). However, the mechanisms that regulate OIS in PDAC are poorly understood. Here,
Algül, Hana   +17 more
core   +1 more source

A case of pancreatic ductal adenocarcinoma with marked infiltration with IgG4-positive cells

open access: yesJournal of Cytology, 2013
A 75-year-old man was diagnosed as having pancreatic ductal carcinoma containing remarkable lymphocytic and plasma cell infiltration, as revealed by the cytological examination of endoscopic ultrasound guided fine-needle aspiration (EUS-FNA) specimen ...
M Yoneda   +3 more
doaj   +1 more source

Pictorial Review of Rare Pancreatic Tumors and Tumor-Like Lesions

open access: yes대한영상의학회지, 2020
Various types of tumors and tumor-like lesions may affect the pancreas. Among them, pancreatic ductal adenocarcinoma is the most common and is generally referred to as “pancreatic cancer.” Recently, the detection rates of rare pancreatic tumors and ...
Seung Jae Lee   +3 more
doaj   +1 more source

A33 shows similar sensitivity to but is more specific than CDX2 as an immunomarker of colorectal carcinoma [PDF]

open access: yes, 2017
Aims: CDX2 is widely used as a sensitive and specific immunomarker for colorectal carcinoma (CRC) but neither this sensitivity nor specificity is absolute. This study is the first known comparison of CDX1 and A33 against CDX2 as immunomarkers for CRC.
Adamczyk, Lukasz A.   +5 more
core   +1 more source

Anaplastic carcinoma of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2018
Background Anaplastic carcinoma of the pancreas is a rare pancreatic neoplasm with a poor prognosis. It is classified as a variant of ductal adenocarcinoma, but the clinical features and treatment of it remain unknown because of its rarity and ...
Kohei Oka   +11 more
doaj   +1 more source

Recent Developments in the Treatment of Pancreatic Cancer

open access: yesActa Médica Portuguesa, 2023
Pancreatic duct adenocarcinoma is currently the sixth-leading cause of cancer death worldwide and the fourth in Europe, with a continuous increase in annual lethality in Portugal during the last two decades.
Jorge Paulino, Hélder Mansinho
doaj   +1 more source

Mesenteric-Portal Vein Resection during Pancreatectomy for Pancreatic Cancer [PDF]

open access: yes, 2015
The aim of the present study was to determine the outcome of patients undergoing pancreatic resection with (VR+) or without (VR 12) mesenteric-portal vein resection for pancreatic carcinoma.
Beltrame, Valentina   +5 more
core   +4 more sources

Home - About - Disclaimer - Privacy